NasdaqGS:ANABBiotechs
Evaluating AnaptysBio (ANAB) Valuation After A Strong 90 Day Share Price Gain
AnaptysBio (ANAB) has drawn investor attention after recent trading left the shares with a 1 day return of 1.6%, a month return near flat, and a past 3 months gain approaching 38%.
See our latest analysis for AnaptysBio.
With the share price at US$43.91, AnaptysBio’s 90 day share price return of 38% contrasts with a small year to date decline, while a very large 1 year total shareholder return suggests momentum has been building over a longer horizon.
If AnaptysBio’s recent move has caught...